ELITE PHARMACEUTICALS INC /NV/ Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $70.6K, a 41.7% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $228K, a 85.6% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Share-based Payment Arrangement, Expense for 2023 was $160K, a 307% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Share-based Payment Arrangement, Expense for 2022 was $39.3K, a 174% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Share-based Payment Arrangement, Expense for 2021 was $14.4K, a 8.89% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.